LMAT - LeMaitre Vascular GAAP EPS of $0.28 misses by $0.03 revenue of $39.5M misses by $0.2M; issues Q1 and FY22 guidance
LeMaitre Vascular press release (NASDAQ:LMAT): Q4 GAAP EPS of $0.28 misses by $0.03. Revenue of $39.5M (+5.3% Y/Y) misses by $0.2M. Q1 2022 Guidance: Sales of $37.7M - $39.7M (consensus of $39.01M); Gross Margin of 66.2%; EPS of $0.26 - $0.30 (consensus of $0.30). 2022 Full Year Guidance: Sales of $162M - $166M (consensus of $166.36M); Gross Margin of 67.2%; EPS of $1.35 - $1.45 (consensus of $1.40).
For further details see:
LeMaitre Vascular GAAP EPS of $0.28 misses by $0.03, revenue of $39.5M misses by $0.2M; issues Q1 and FY22 guidance